| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
486 |
472 |
$25K |
| 99215 |
Prolong outpt/office vis |
79 |
77 |
$6K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
43 |
40 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
201 |
166 |
$126.68 |
| J7050 |
Infusion, normal saline solution, 250 cc |
110 |
92 |
$53.90 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
605 |
587 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
397 |
384 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
124 |
122 |
$0.00 |
| 4192F |
|
12 |
12 |
$0.00 |
| 1170F |
|
67 |
66 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
470 |
458 |
$0.00 |
| M1007 |
>=50% of total number of a patient's outpatient ra encounters assessed |
79 |
78 |
$0.00 |
| M1003 |
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy |
53 |
51 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16 |
14 |
$0.00 |